drugset / Trial / NCT00426023

Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis

NCT00426023

RandomizedCrossoverQuadruple-blindTreatment

Summary

This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.

Timeline

Start
2007-02
Primary completion
2008-10
Completion
2008-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.05 % Topical
Comparator Ketotifen Small molecule 0.025 % Topical